Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Doxorubicin-Loaded Nk Exosomes Enable Cytotoxicity Against Triple-Negative Breast Cancer Spheroids Publisher



Hashemi ZS1 ; Ghavami M2 ; Mohammadi F3 ; Shokrollahi Barough M1 ; Shokati F4 ; Asghari S1 ; Khalili S5 ; Akbari Yekta M4 ; Ghavamzadeh A6 ; Forooshani RS1
Authors
Show Affiliations
Authors Affiliations
  1. 1. ATMP Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
  2. 2. Pathology Department, Dalhousie University, Halifax, Canada
  3. 3. Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Biomaterials and Tissue Engineering Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran
  5. 5. Department of Biology Sciences, Shahid Rajaee Teacher Training University, Tehran, Iran
  6. 6. Cancer and Cell Therapy Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Iranian Journal of Basic Medical Sciences Published:2024


Abstract

Objective(s): Natural killer (NK) cells are the most professional innate immune cells that initiate extracellular apoptosis via cytotoxic granules in malignant cells. Antitumoral properties of NK-derived exosomes (Exos) are attributed to their parent cells. Loading drugs into Exos as a carrier can enhance their effect and enable targeted delivery. In the present study, we aim to deliver Doxorubicin (DOX) to the breast cancer spheroids by NK-Exos. Materials and Methods: Peripheral blood mononuclear cells (PBMC) were used to harvest NK cells, and NK-Exos were isolated from NK cell expansion medium using an Exo-spinTM kit. DOX was loaded via the ultrasonication method. AO/EtBr, Annexin/PI, DAPI, MTT, and spheroids of human breast cancer were used to track the cytotoxic effect of DOX-NK-Exos. The colony formation assay, scratch and transwell assays, Real-Time PCR for p53 and VEGF-A, and WB for protein expression were also performed. Results: When compared to free DOX, all viability tests validated the inhibitory effects of DOX-NK-Exos. The obtained results indicated that DOX-NK-Exos selectively reduced tumor cell viability and spared fibroblast and MCF-10A as noncancerous cells. Long after spheroid treatment, DOX-NK-Exos’ remarkable effect persisted. Conclusion: Human breast carcinoma mass treated with DOX-NK-Exos underwent apoptosis and showed a strong inhibitory effect on proliferation. Thus, they can reduce the side effects of chemotherapeutics and can be used as drug carriers with selective toxicity. Additionally, the additive action of this combination formula results in a more severe loss in cell viability. © 2024 mums.ac.ir All rights reserved.
Related Docs
View other Related Docs
1. Natural Killer Cell-Derived Exosomes for Cancer Immunotherapy: Innovative Therapeutics Art, Cancer Cell International (2023)
2. Novel Delivery of Sorafenib by Natural Killer Cell-Derived Exosomes-Enhanced Apoptosis in Triple-Negative Breast Cancer, Nanomedicine (2023)
3. Bioactivity of Exosomes Derived From Trained Natural Killer Cells Versus Non-Trained One: More Functional and Antitumor Activity, BioMed Research International (2022)
4. Current Knowledge on Therapeutic, Diagnostic, and Prognostics Applications of Exosomes in Multiple Myeloma: Opportunities and Challenges, Archives of Biochemistry and Biophysics (2024)
5. Designer Exosomes: A New Platform for Biotechnology Therapeutics, BioDrugs (2020)
6. Exosomes As a Next-Generation Drug Delivery System: An Update on Drug Loading Approaches, Characterization, and Clinical Application Challenges, Acta Biomaterialia (2020)
7. Natural Killer Cells and Their Exosomes in Viral Infections and Related Therapeutic Approaches: Where Are We?, Cell Communication and Signaling (2023)
8. Exosomes and Micrornas in Biomedical Science, Synthesis Lectures on Biomedical Engineering (2022)
Experts (# of related papers)
View all Related Experts
Hamid Reza Mirzaei (4)
Somayeh Ebrahimi Barough (3)
Other Related Docs
9. The Role of Nk Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia, Stem Cell Reviews and Reports (2023)
10. Advances in Natural Killer Cell Therapies for Breast Cancer, Immunology and Cell Biology (2023)
11. Extracellular Vesicles-Based Drug Delivery Systems: A New Challenge and the Exemplum of Malignant Pleural Mesothelioma, International Journal of Molecular Sciences (2020)
12. Characterization of an Engineered Ace2 Protein for Its Improved Biological Features and Its Transduction Into Mscs: A Novel Approach to Combat Covid-19 Infection, International Journal of Biological Macromolecules (2024)
13. Extracellular Vesicles Biogenesis, Isolation, Manipulation and Genetic Engineering for Potential in Vitro and in Vivo Therapeutics: An Overview, Frontiers in Bioengineering and Biotechnology (2022)
14. The Extracellular Vesicles-Derived From Mesenchymal Stromal Cells: A New Therapeutic Option in Regenerative Medicine, Journal of Cellular Biochemistry (2018)
15. Targeted Delivery of Doxorubicin by Sp5-52 Peptide Conjugated Exosome Nanoparticles Into Lung Tumor: An in Vitro and in Vivo Study, Journal of Drug Delivery Science and Technology (2024)
16. The Potential Application of Encapsulated Exosomes: A New Approach to Increase Exosomes Therapeutic Efficacy, Biomedicine and Pharmacotherapy (2023)
17. Texosome-Based Drug Delivery System for Cancer Therapy: From Past to Present, Cancer Biology and Medicine (2015)
18. Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications, Current Medicinal Chemistry (2021)
19. Natural Killer Cell Epigenetic Reprogramming in Tumors and Potential for Cancer Immunotherapy, Epigenomics (2023)
20. Diagnostic and Therapeutic Potential of Exosomes in Cancer: The Beginning of a New Tale?, Journal of Cellular Physiology (2017)
21. Additive Effect of Metastamir-193B and Breast Cancer Metastasis Suppressor 1 As an Anti-Metastatic Strategy, Breast Cancer (2019)
22. Extracellular Vesicles As a Neprilysin Delivery System Memory Improvement in Alzheimer’S Disease, Iranian Journal of Pharmaceutical Research (2020)
23. Increasing the Sensitivity and Accuracy of Detecting Exosomes As Biomarkers for Cancer Monitoring Using Optical Nanobiosensors, Cancer Cell International (2024)
24. Recent Advances on the Application of Nanobiomimetic Structures As Drug Delivery Systems, Journal of Drug Delivery Science and Technology (2024)
25. Impact of Atorvastatin Loaded Exosome As an Anti-Glioblastoma Carrier to Induce Apoptosis of U87 Cancer Cells in 3D Culture Model, Biochemistry and Biophysics Reports (2020)
26. Exosomal Mirnas From Highly Metastatic Cells Can Induce Metastasis in Non-Metastatic Cells, Life Sciences (2019)
27. Mesenchymal Stem Cell-Derived Antimicrobial Peptides As Potential Anti-Neoplastic Agents: New Insight Into Anticancer Mechanisms of Stem Cells and Exosomes, Frontiers in Cell and Developmental Biology (2022)
28. Phase I Non-Randomized Clinical Trial of Allogeneic Natural Killer Cells Infusion in Acute Myeloid Leukemia Patients, BMC Cancer (2023)
29. Safety and Feasibility Study of Ex Vivo Expanded Allogeneic-Nk Cells Infusion in Patients With Acute Pneumonia Caused by Covid-19, Pilot and Feasibility Studies (2023)
30. Exosome Engineering in Cell Therapy and Drug Delivery, Inflammopharmacology (2023)
31. The Tricks for Fighting Against Cancer Using Car Nk Cells: A Review, Molecular and Cellular Probes (2022)
32. Exosomes As Cutting-Edge Therapeutics in Various Biomedical Applications: An Update on Engineering, Delivery, and Preclinical Studies, Biochimie (2023)
33. Car-Engineered Nk Cells; a Promising Therapeutic Option for Treatment of Hematological Malignancies, Stem Cell Research and Therapy (2021)
34. Adoptive Nk-Cell Transfer As a Potential Treatment Paradigm for Wilms Tumor: A Preclinical Study, Pediatric Blood and Cancer (2022)
35. Assessing the Prognostic Factors, Survival, and Recurrence Incidence of Triple Negative Breast Cancer Patients, a Single Center Study in Iran, PLoS ONE (2019)
36. Inhibition of Breast Cancer Metastasis by Co-Transfection of Mir-31/193B-Mimics, Iranian Journal of Basic Medical Sciences (2018)
37. Harnessing the Power of Exosomes for Diagnosis, Prognosis, and Treatment of Hematological Malignancies, Stem Cell Research and Therapy (2025)
38. Current Understanding of Therapeutic and Diagnostic Applications of Exosomes in Pancreatic Cancer, Pancreas (2025)
39. The Role of the Natural Killer (Nk) Cell Modulation in Breast Cancer Incidence and Progress, Molecular Biology Reports (2022)
40. Focusing on Exosomes to Overcome the Existing Bottlenecks of Car-T Cell Therapy, Inflammation and Regeneration (2024)
41. Evaluation of Exosomal Mir-9 and Mir-155 Targeting Pten and Dusp14 in Highly Metastatic Breast Cancer and Their Effect on Low Metastatic Cells, Journal of Cellular Biochemistry (2019)
42. Targeted Expression of a Designed Fusion Protein Containing Bmp2 Into the Lumen of Exosomes, Biochimica et Biophysica Acta - General Subjects (2024)
43. Mesenchymal Stem Cell Exosomes: A Two-Edged Sword in Cancer Therapy, International Journal of Nanomedicine (2019)
44. Phase I Study of Safety and Efficacy of Allogeneic Natural Killer Cell Therapy in Relapsed/Refractory Neuroblastomas Post Autologous Hematopoietic Stem Cell Transplantation, Scientific Reports (2024)
45. Natural Killer Cells and Cancer Therapy, What We Know and Where We Are Going, Immunotherapy (2019)
46. Antileukemia Activity of Human Natural Killer Cell-Derived Nanomagic Bullets Against Acute Myeloid Leukemia (Aml), International Journal of Hematology-Oncology and Stem Cell Research (2024)
47. Targeted Cancer Therapy Through Antibody Fragments-Decorated Nanomedicines, Journal of Controlled Release (2017)
48. Evaluation of Differentiation Quality of Several Differentiation Inducers of Bone Marrow-Derived Mesenchymal Stem Cells to Nerve Cells by As-Sessing Expression of Beta-Tubulin 3 Marker: A Systematic Review, Current Stem Cell Research and Therapy (2021)
49. Application of Plant-Derived Exosome-Like Nanoparticles in Drug Delivery, Pharmaceutical Development and Technology (2023)
50. Role of Exosomes in the Treatment of Diseases, Synthesis Lectures on Biomedical Engineering (2022)